Movano (NASDAQ:MOVE) CTO Michael Aaron Leabman Sells 2,076 Shares

January 15, 2026 by InsiderTrades.com

Key Points

CTO sale: Movano CTO Michael Aaron Leabman sold 6,845 shares on Jan. 14 at $6.66 for $45,587.70, cutting his stake to 22,639 shares (a 23.22% reduction).
Clustered insider selling: Leabman and other insiders (including the CFO) completed multiple sales in early January, which—given Movano’s low float—could meaningfully pressure sentiment and the stock price.
Weak fundamentals and analyst view: Movano’s market cap is roughly $5.8M, recent revenue was about $0.08M with a large EPS loss, and the stock carries an average analyst rating of "Sell".

Movano Inc. (NASDAQ:MOVE - Get Free Report) CTO Michael Aaron Leabman sold 2,076 shares of the business's stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $6.94, for a total transaction of $14,407.44. Following the completion of the transaction, the chief technology officer directly owned 29,484 shares in the company, valued at $204,618.96. This represents a 6.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Checkmate in the Cloud: ServiceNow's Shopping Spree

Michael Aaron Leabman also recently made the following trade(s):

On Wednesday, January 14th, Michael Aaron Leabman sold 6,845 shares of Movano stock. The shares were sold at an average price of $6.66, for a total value of $45,587.70.
On Monday, January 12th, Michael Aaron Leabman sold 3,377 shares of Movano stock. The stock was sold at an average price of $7.01, for a total transaction of $23,672.77.
On Friday, January 9th, Michael Aaron Leabman sold 783 shares of Movano stock. The stock was sold at an average price of $7.27, for a total transaction of $5,692.41.
On Thursday, January 8th, Michael Aaron Leabman sold 3,593 shares of Movano stock. The stock was sold at an average price of $7.26, for a total value of $26,085.18.
On Wednesday, January 7th, Michael Aaron Leabman sold 3,293 shares of Movano stock. The shares were sold at an average price of $7.34, for a total value of $24,170.62.

Movano Price Performance

Shares of MOVE opened at $6.92 on Thursday. The firm has a 50 day simple moving average of $8.89 and a 200-day simple moving average of $7.56. The stock has a market cap of $5.78 million, a price-to-earnings ratio of -0.64 and a beta of 0.79. Movano Inc. has a 1-year low of $4.67 and a 1-year high of $58.76.

Qualcomm Just Hit A 52 Week High—Time to Buckle Up

Movano (NASDAQ:MOVE - Get Free Report) last announced its quarterly earnings data on Friday, November 14th. The technology company reported ($4.73) earnings per share (EPS) for the quarter, beating the consensus estimate of ($7.00) by $2.27. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%. The business had revenue of $0.08 million for the quarter, compared to the consensus estimate of $3.88 million.

Key Stories Impacting Movano

Here are the key news stories impacting Movano this week:

Positive Sentiment: Institutional buying: Citadel Advisors added a new stake in Movano in Q3 (49,262 shares), which signals some institutional interest and provides a modest demand anchor for the stock. MarketBeat MOV E profile
Positive Sentiment: Short interest declined in late December (down ~29% vs. mid‑December), lowering one source of short‑squeeze pressure and marginally reducing downward technical risk. Short interest detail
Neutral Sentiment: Broader market/geo risk: U.S. stocks were weaker amid rising geopolitical tensions today, which hit small-cap and tech names harder and likely amplified Movano’s downside. RTT News: Market Move
Negative Sentiment: Significant insider selling — CTO Michael Aaron Leabman sold multiple tranches (e.g., 6,845 shares on Jan. 14 at ~$6.66; earlier sales Jan. 12–13 at ~$7.01–$6.94). Large, clustered insider sales in a low‑float stock can weigh heavily on sentiment and price. SEC filing (Leabman)
Negative Sentiment: Additional insider selling — CFO Jeremy Cogan disclosed recent sales (8,218 shares on Jan. 6 at ~$7.79 and 1,879 shares on Jan. 5 at ~$8.35), further reducing insider ownership and pressuring sentiment. SEC filing (Cogan)
Negative Sentiment: Weak fundamentals amplify risk — Movano’s latest quarterly report (Nov. 14) showed a large EPS loss despite beating the consensus loss, with essentially negligible revenue (~$0.08M vs. est. ~$3.9M). For a tiny public company, very low top‑line and deeply negative margins increase execution and dilution risk. Earnings summary
Negative Sentiment: Structural/analyst backdrop: Movano’s market cap is very small (~$5–6M) with low average volume and an average analyst rating near "Sell" — factors that magnify volatility and make recovery catalysts harder to materialize absent meaningful operational progress. Company profile & ratings

Analyst Ratings Changes

Defense Contractor Stocks Explained, Plus Investment Guide

MOVE has been the topic of several analyst reports. Wall Street Zen raised shares of Movano to a "hold" rating in a research note on Saturday, December 20th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Movano in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Sell".

Check Out Our Latest Stock Analysis on MOVE

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC acquired a new stake in shares of Movano Inc. (NASDAQ:MOVE - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 49,262 shares of the technology company's stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano at the end of the most recent quarter. Institutional investors and hedge funds own 16.64% of the company's stock.

About Movano

(Get Free Report)

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company's core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano's flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.